Evidence map›Paper›PMID 41693559›Full record

ArticleCirculation. Population health and outcomes2026

Coronary Artery Calcium Progression and Cognitive Function in Midlife-The Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Masayuki Teramoto, James G Terry, Mark J Pletcher, Gregory M Marcus, Thomas J Hoffmann, Stephen Sidney, Kristine Yaffe

Abstract read
In one paragraph

Article in Circulation. Population health and outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Masayuki TeramotoDepartment of Epidemiology and Biostatistics (M.T., M.J.P., T.J.H., K.Y.), University of California San Francisco, San Francisco, CA.ORCID 0000-0002-2318-2447
James G TerryDepartment of Radiology, Vanderbilt University Medical Center, Nashville, TN (J.G.T.).ORCID 0000-0001-6659-3441
Mark J PletcherDepartment of Epidemiology and Biostatistics (M.T., M.J.P., T.J.H., K.Y.), University of California San Francisco, San Francisco, CA.ORCID 0000-0002-6966-1312
Gregory M MarcusDepartment of Epidemiology and Biostatistics (M.T., M.J.P., T.J.H., K.Y.), University of California San Francisco, San Francisco, CA.ORCID 0000-0001-5197-7696
Thomas J HoffmannDepartment of Epidemiology and Biostatistics (M.T., M.J.P., T.J.H., K.Y.), University of California San Francisco, San Francisco, CA.
Stephen SidneyDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA (S.S.).ORCID 0000-0001-7454-5036
Kristine YaffeDepartment of Epidemiology and Biostatistics (M.T., M.J.P., T.J.H., K.Y.), University of California San Francisco, San Francisco, CA.

Funding

Population Based Research for Alzheimer's Innovation (POP BRAIN)R35AG071916 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAFFE, KRISTINE · 2021 to 2024
$3.8M
Lifecourse CVD Risk and Midlife Cognitive Trajectories and Brain Aging: Implications for Alzheimer's and Dementia PreventionR01AG063887 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI YAFFE, KRISTINE · 2019 to 2022
$3.0M
Lifecourse Predictors and Mechanisms of Early Clinical ADRD among Black and White Adults in their SixtiesR01AG091431 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kristine Yaffe · 2025 to 2026
$2.6M
NIA NIH HHS R01 AG063887NIA NIH HHS R01 AG091431NIA NIH HHS R35 AG071916
6 · The paper itself

Abstract

backgroundWe aimed to examine how coronary artery calcium (CAC) and its progression relate to cognitive function in midlife, an important time for cognitive aging.

methodsWe studied participants enrolled in the prospective CARDIA (Coronary Artery Risk Development in Young Adults) study, a longitudinal cohort of Black and White adults aged 18 to 30 years at baseline, who completed CAC measurements using computed tomography at year 15 (2000-2001; our baseline), had at least 1 follow-up CAC measurement at years 20 (2005-2006) or 25 (2010-2011), and completed cognitive assessments with a battery of 5 tests at years 30 (2015-2016) or 35 (2020-2022). CAC progression was defined as: (1) CAC >0 at follow-up among participants with baseline CAC=0; (2) an annualized change of ≥10 units at follow-up among those with 0<baseline CAC <100; or (3) an annualized percent change ≥10% among those with baseline CAC ≥100. We used linear regression to estimate the cognitive performance (z-standardized) with 95% confidence intervals (CIs) of each cognitive test by baseline CAC score (0 versus >0) and CAC progression.

resultsAmong the 2341 participants (mean baseline age 40.3±3.6 years; 56% female), baseline CAC >0 (9%) was associated with lower processing speed, verbal memory, and global cognition, whereas CAC progression (26%) was associated with lower processing speed and global cognition after adjusting for demographics, education, physical activity, depressive symptoms, APOE ε4 allele, and baseline CAC score. The standardized cognitive differences (95% CI) for CAC progression versus no progression were -0.14 (95% CI, -0.23 to -0.06) for the Digit Symbol Substitution Test and -0.09 (95% CI, -0.17 to -0.01) for the Montreal Cognitive Assessment.

conclusionsCAC progression was associated with worse midlife processing speed and global cognition, independent of baseline CAC score and established risk factors. Repeated CAC assessments may offer clinical value for identifying individuals at increased risk for midlife cognitive decline.

Indexed as

CalciumCognitionCoronary Artery DiseaseCoronary VesselsVascular CalcificationAdolescentAdultDisease ProgressionFemaleHumansLongitudinal StudiesMaleProspective StudiesRisk FactorsYoung AdultCalciumatherosclerosiscognitive agingcohort studiescoronary artery diseaserisk factors

Identifiers

PMID41693559
PMCPMC13094724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.